Mylan named in class-action suit over EpiPen

MORGANTOWN, W.Va. — Mylan NV has been named in a class-action racketeering suit.

CNBC reports the suit stems from alleged price gauging for the auto-injector EpiPen used to counter deadly allergic reactions.

According to the outlet, “The suit alleges that the “skyrocketing” list price of EpiPen for consumers was the result of Mylan’s payments of rebates to pharmacy benefit managers — including CVS Caremark, Express Scripts and Optum Rx — which handle prescription drug benefit programs for insurance plans.”

The class-action racketeering suit was filed in U.S. District Court in Seattle, Washington on Monday, April 3.

Following criticism over pricing practices of its auto injection allergy drug, Mylan previously agreed to a settlement with the U.S. Department of Justice and federal regulators.

The price of Mylan’s EpiPen Auto-Injector including the EpiPen Jr. has increased more than 500 percent in nine years.

A generic version of the EpiPen was launched December.





More News

News
As Yeager Airport's Wildlife Patrol Dog turns 7, a new dog comes in to learn from him
The new Border Collie is getting acclimated and receiving training for his soon-to-be role.
March 28, 2024 - 6:30 pm
News
Dunlow Volunteer Fire Department closes
The Dunlow VFD did not have a valid workers compensation insurance policy.
March 28, 2024 - 6:20 pm
News
PEIA examines financial effects of new law meant to ensure local pharmacies get fair reimbursements
Gov. Jim Justice signed Senate Bill 453 into law this week.
March 28, 2024 - 4:11 pm
News
Barbour County woman sentenced after death case sent back to circuit court by Supreme Court
Carli Reed sentenced on voluntary manslaughter conviction.
March 28, 2024 - 4:11 pm